Explore popular drugs in clinical trials

Check which drugs are currently being frequently studied.

See also our rare diseases glossary and popular diseases list.

Starting by letter

To open the drugs glossary, select a letter from the list below.

Most popular drugs

The list below features the most popular substances currently involved in ongoing clinical trials.

Drug trials
Pembrolizumab 441
Sodium Chloride 403
Carboplatin 329
Cisplatin 274
Paclitaxel 245
Fluorouracil 226
Oxaliplatin 218
Nivolumab 205
Dexamethasone 203
Rituximab 189
Cyclophosphamide 183
Durvalumab 157
Bevacizumab 157
Paracetamol 154
Capecitabine 152
Atezolizumab 145
Docetaxel 127
Prednisone 125
Tocilizumab 120
Prednisolone 116
Gemcitabine 114
Venetoclax 113
Etoposide 113
Mycophenolate Mofetil 111
Pemetrexed 109
Doxorubicin Hydrochloride 104
Lenalidomide 97
Infliximab 93
Ipilimumab 89
Acetylsalicylic Acid 87
Folinic Acid 87
Semaglutide 86
Placebo 83
Paclitaxel Albumin-Bound 81
Methotrexate 77
Cytarabine 77
Daratumumab 77
Fludarabine Phosphate 75
Calcium Folinate 74
Letrozole 73
Bortezomib 70
Olaparib 70
Gemcitabine Hydrochloride 68
Dapagliflozin 66
Obinutuzumab 65
Trastuzumab 65
Azacitidine 65
Fulvestrant 62
Cetuximab 61
Tacrolimus 61
Methylprednisolone 61
Lenvatinib 60
Irinotecan 58
Irinotecan Hydrochloride Trihydrate 58
Vincristine Sulfate 57
Temozolomide 56
Cemiplimab 54
Trastuzumab Deruxtecan 53
Enzalutamide 51
Apixaban 49
Dexamethasone Sodium Phosphate 49
Codeine Phosphate 48
Betamethasone Sodium Phosphate 48
Lidocaine Hydrochloride Monohydrate 47
Exemestane 47
Buclizine Hydrochloride 46
Anastrozole 46
Potassium Chloride 46
Empagliflozin 46
Hydrocortisone 45
Lidocaine Hydrochloride 45
Amoxicillin 44
Ribociclib 44
Doxorubicin 43
Pertuzumab 43
Adalimumab 43
Clopidogrel 42
Ruxolitinib 41
Tenofovir Alafenamide 41
Rivaroxaban 41
Abemaciclib 41
Ibrutinib 40
Oxygen 40
Pomalidomide 40
Clavulanic Acid 39
Atorvastatin 39
Ropivacaine Hydrochloride 39
Metformin Hydrochloride 39
Ifosfamide 38
Carfilzomib 38
Palbociclib 38
Propofol 38
Bendamustine Hydrochloride 38
Emtricitabine 37
Acalabrutinib 37
Dostarlimab 37
Cyclophosphamide Monohydrate 37
Pemetrexed Disodium 37
Dexamethasone Phosphate 36
Sulfamethoxazole 36

New drugs in trials

The list below features the new substances involved to ongoing clinical trials.

#1 AZD0120

Clinical trials are investigating AZD0120 in people with relapsed or refractory multiple myeloma, a cancer that has returned or no longer responds to treatment.

1 week ago
#2 STREPTOCOCCUS VIRIDANS

Clinical trials investigating "STREPTOCOCCUS VIRIDANS" are studying whether a related study treatment can reduce respiratory infections in children.

1 week ago
#3 STREPTOCOCCUS PYOGENES

Clinical trials investigating STREPTOCOCCUS PYOGENES are studying a treatment called PMBL (Ismigen) in children with respiratory tract infections.

1 week ago
#4 AZD1163

Clinical trials are investigating AZD1163 in adults with moderately to severely active rheumatoid arthritis.

1 week ago
#5 AZD5335

Clinical trials are investigating AZD5335 in women with advanced platinum-resistant epithelial ovarian cancer.

1 week ago
#6 IMB 101

Clinical trials are studying NAV-240 in adults with moderate-to-severe hidradenitis suppurativa.

1 week ago

Drugs starting by l

  • LY3841136 SODIUM

    ,

    Clinical trials are studying LY3841136 SODIUM, also called eloralintide, in people with obesity or overweight and related health problems. These studies look at whether it helps with body weight and, in some trials, sleep apnea or knee pain from osteoarthritis. Most trials are Phase 3 studies in adults.

  • LY3848575

    ,

    Clinical trials are investigating LY3848575 in people with painful distal sensory polyneuropathy, a type of nerve damage that can cause pain. The main goal is to see whether LY3848575 can reduce pain better than placebo and to measure safety and other study results.

  • Ly3871801

    ,

    Clinical trials are studying Ly3871801 in adults with rheumatoid arthritis. These studies are looking at whether it can improve disease activity and help more people reach meaningful treatment responses. The main focus is on efficacy, with placebo used for comparison.

  • Ly4100511

    ,

    Clinical trials are studying Ly4100511 in adults with moderate-to-severe plaque psoriasis. The main goal is to compare different dose regimens with placebo and measure how well the treatment works and how many people improve. These studies help show whether Ly4100511 may be useful for this skin condition.

  • LY4170156

    ,

    Clinical trials are investigating LY4170156, also called Sofetabart Mipitecan, in people with ovarian cancer and related cancers. This article explains what the trials are studying, who may join, and how the studies measure benefit and safety. The main goal is to compare LY4170156-based treatment with standard treatment options in different ovarian cancer groups.

  • Lymecycline

    ,

    Clinical trials investigating Lymecycline are studying how it performs in patient groups with acne and hidradenitis suppurativa. These studies look at treatment results and compare Lymecycline with other therapies or standard care. The trials include people with moderate acne and patients with Hurley stage 2 active hidradenitis suppurativa.

  • LYSERGIDE

    , , , ,

    Clinical trials are investigating LYSERGIDE in different patient groups to see whether it can help with symptoms and whether it is safe and effective in study settings. The trials in this article include adults with generalized anxiety disorder, chronic cluster headache, and attention deficit hyperactivity disorder (ADHD).

  • Lysine Acetate

    , , ,

    Clinical trials investigating Lysine Acetate are studying how it is used in different surgical and kidney disease settings. These trials look at outcomes such as muscle loss, infections, and muscle mass, and they mainly include adults after major surgery or with advanced chronic kidney disease.

  • Lysine Aspirin

    ,

    Clinical trials investigating Lysine Aspirin are studying its use in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA). The main goal is to learn whether a precision-medicine approach can improve symptoms and quality of life. These trials focus on adults with MINOCA and measure outcomes such as angina status and patient-reported quality of life.

  • Lysine Hydrochloride

    , , , ,

    Clinical trials listed here are investigating Lysine Hydrochloride as part of treatment plans in several studies. The trials look at safety, dose finding, and treatment benefit in groups such as children with neuroblastoma, adults with GEP-NETs, and patients with lung cancer or hemodialysis-related muscle changes.